Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Neoplasms × Prednisone × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Lymphoma, Large B-Cell, Diffuse 22 Prostatic Neoplasms 19 Burkitt Lymphoma 16 Lymphoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Follicular 8 Neoplasm Metastasis 7 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, T-Cell, Peripheral 5 Lymphoma, B-Cell, Marginal Zone 5 Multiple Myeloma 4 Leukemia 4 Hodgkin Disease 4 Recurrence 3 Neoplasms, Plasma Cell 3 Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Thrombocythemia, Essential 2 Primary Myelofibrosis 2 Myeloproliferative Disorders 2

Interventions

Paclitaxel 67 Trastuzumab 65 Fulvestrant 45 Cyclophosphamide 45 Capecitabine 36 pembrolizumab 34 Lapatinib 34 Docetaxel 34 palbociclib 29 Carboplatin 27 Letrozole 25 Doxorubicin 20 Gemcitabine 19 olaparib 18 Everolimus 17 abemaciclib 16 Bevacizumab 16 Ado-Trastuzumab Emtansine 16 pertuzumab 15 Vinorelbine 15 Magnetic Resonance Spectroscopy 15 Cisplatin 15 ribociclib 14 exemestane 14 Taxes 14 Radiotherapy 14 Nivolumab 13 130-nm albumin-bound paclitaxel 12 veliparib 11 Filgrastim 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02776436 2026-02-17

REDEX

Leiden University Medical Center

Phase 1 Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡